Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study - Colucci, G; Labianca, R; Di Costanzo, F (Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2010)
et al.